Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.
The Ontario Institute for Cancer Research (OICR) brings together a community of scientists, clinicians, patients and innovators to take on the biggest challenges in cancer.
Stay up to date with our latest stories, findings, and partnerships.
OICR will welcome the internationally recognized clinician-scientist and research leader in August 2026.
Our new report 20 Years of Changing Lives is a snapshot of OICR’s impact over the years, the difference it is making today and the future of cancer research in Ontario.
Through cutting-edge research, collaborative networks and strategic investments, we are improving health, building a stronger economy and making a global impact.
46,000+ patients accessed new cancer innovations through these OICR-supported clinical trials.
OICR and FACIT support more than 1,500 highly-skilled jobs in STEM fields on an annual basis, more than half of which are at start-ups across Ontario.
OICR supports cancer research at 20 communities across Ontario, including 10 universities, 25 hospitals and 10 institutes.
Be first to know about news, events and funding opportunities from OICR.
We’re accelerating and supporting cancer research across the province.
We deliver real-world solutions that are finding cancer earlier, treating it more effectively and improving outcomes in Ontario and around the world.
We drive the development and adoption of life-changing innovations.
We bolster Ontario’s global leadership in cancer research.
We invest in cancer research innovations to build economic value for Ontario.
Working with our commercialization partner FACIT, we support Ontario innovations to create local jobs and new companies, attract investment to the province and bring new discoveries to patients worldwide.
See the latest research news from Ontario’s cancer research institute.
The Canadian Cancer Clinical Trials Network, its member cancer centres, and partners continue their work to eliminate barriers to clinical trial access for Canadians
TMIST, co-led by Canadian researchers, is working to determine whether a newer form of breast imaging can better detect aggressive breast cancers. The Tomosynthesis
OICR will welcome the internationally recognized clinician-scientist and research leader in August 2026. We are very excited to announce that Dr. Aaron Schimmer has
In the CAN-PREFER trial, OICR researchers are trialing accessible, patient-friendly reports from cancer biomarker testing. You shouldn’t need a PhD to understand your own
- Hon. Nolan Quinn
Minister of Colleges, Universities, Research Excellence and Security
We support a thriving community of programs, networks and initiatives advancing cancer research in Ontario and beyond.
